Clinical Trials on Healthy Subjects(Only Men)

Total 1251 results

Xuanzhu Biopharmaceutical Co., Ltd.

Not yet recruiting

Drug-drug Interaction Study of XZP-3621 Tablet

Healthy Subjects

China
Keymed Biosciences Co.Ltd

Not yet recruiting

Multiple Ascending Dose Study of CM338 in Healthy Volunteers

Healthy Subjects
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)

Healthy Subjects

United States
Alebund Pty Ltd

Completed

A Safety, Tolerability, and Pharmacokinetics Study of AP303 in Healthy Subjects

Healthy Subjects

Australia
Cutia Therapeutics（Wuxi）Co.,Ltd

Completed

A Phase 1 Clinical Study of CU-20401 in Chinese Healthy Population

Healthy Subjects

China
Alebund Pty Ltd

Completed

A Pharmacodynamic Effect Study of AP301 in Healthy Volunteers

Healthy Subjects

Australia
Tavotek Biotherapeutics

Active, not recruiting

Study of TAVO101 in Healthy Volunteers

Healthy Subjects

Australia
Tavotek Biotherapeutics

Completed

Study of TAVO103A in Healthy Volunteers

Healthy Subjects

United States
CTI BioPharma
Covance

Completed

To Evaluate the Cardiac Safety and PK Following a Single Oral Dose Administration of Pacritinib in Healthy Subjects

Healthy Subjects

United States
CTI BioPharma
Covance

Completed

Study to Assess the Relative Bioavailability of Pacritinib Following Oral Administration as Capsule and Solution Formulations in Healthy Subjects

Healthy Subjects

United States
Carnegie Mellon University

Completed

Mind-body Awareness Training and Brain-computer Interface

Healthy Subjects

United States
Diffusion Pharmaceuticals Inc

Completed

Safety and Efficacy of Trans Sodium Crocetinate (TSC) in Enhancing Tissue Oxygen Levels in Healthy Volunteers

Healthy Subjects

United States
Dong Wha Pharmaceutical Co. Ltd.

Completed

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component(Empagliflozin and Metformin) in Healthy Adult Volunteers in Fast Condition.

Healthy Subjects

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers

Healthy Subjects

Korea, Republic of
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects

Healthy Subjects

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Evaluate the Effect of a Single Oral Dose of MT-7117 on the QT/QTc Interval in Healthy Subjects

Healthy Subjects

United States
Innovent Biologics (Suzhou) Co. Ltd.

Completed

A Study of IBI353 (Orismilast) in Chinese Healthy Adults

Healthy Subjects

China
Vigonvita Life Sciences

Completed

Evaluate the Effect of TPN171H on the QT/QTc Interval in Healthy Volunteers

Healthy Subjects

China
Idorsia Pharmaceuticals Ltd.

Completed

To Study the Effect of Aprocitentan on the Electrical Activity of the Heart in Healthy Men and Women

Healthy Subjects

Germany
Idorsia Pharmaceuticals Ltd.

Completed

To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.

Healthy Subjects

France
Fundación Pública Andaluza para la Investigación...

Active, not recruiting

Target Mitochondrial Fitness, Chronobiology and Metabolism (PI19/00507)

Healthy Subjects

Spain
SK Chemicals Co., Ltd.

Completed

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Healthy Subjects

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Healthy Subjects

Korea, Republic of
Innovent Biologics (Suzhou) Co. Ltd.

Active, not recruiting

A Study to Evaluate the Similarity in Pharmacokinetics and Safety of IBI310 and Ipilimumab（YERVOY）in Adult Healthy Chinese Male Volunteers

Healthy Subjects

China
Protagonist Therapeutics, Inc.

Completed

Pharmacokinetics of PN-232 in Healthy Volunteers

Healthy Subjects

Australia
Brigham and Women's Hospital

Completed

Effect of Statin Use on Aldosterone Secretion

Healthy Subjects

United States
PegBio Co., Ltd.
Covance

Completed

A Phase 1, Double-blind, Randomized, Placebo-controlled, Single- and Multiple-dose Escalating Study

Healthy Subjects

United States
Future University in Egypt

Completed

Bioequivalence Study of Aripiprazole in Healthy Adult Subjects Under Fasting Condition

Healthy Subjects

Egypt
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Phase I Randomized, Double-Blind, Placebo-Controlled, Parallel Group Clinical Study of ICP-332 in Healthy Subjects

Healthy Subjects

China
Centre Hospitalier Universitaire de Nice

Completed

Cohort of Healthy People in Brain MRI, Together With a Language and Cognitive Assessment at the University Hospital of Nice (NHB)

Healthy Subjects

France
Venatorx Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

VNRX-5024 Safety and PK in Healthy Adult Volunteers

Healthy Subjects

Netherlands
Vigonvita Life Sciences

Completed

Safety and Pharmacokinetics Study of Single Ascending Doses of VV116 in Healthy Volunteers

Healthy Subjects

China
The Affiliated Hospital of Qingdao University

Completed

Study on the Human Bioequivalence of Oseltamivir Phosphate For Oral Suspension

Healthy Subjects

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study to Evaluate Relative Bioavailability and Food-Effect of HA121-28 Tablet B in Healthy Subjects

Healthy Subjects

China
Ark Biosciences Inc.

Completed

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Ziresovir in Healthy Subjects

Healthy Subjects

United States
Astellas Pharma Global Development, Inc.

Completed

A Study to Assess the Effect of Food With Fezolinetant in Healthy Female Participants

Healthy Subjects

United States
MacroGenics

Completed

Phase 1 Study of MGD010 in Healthy Subjects

Healthy Subjects

United States
Celldex Therapeutics

Completed

A Phase 1 Study of Subcutaneous CDX-0159 in Healthy Subjects

Healthy Subjects

United States
Tetraphase Pharmaceuticals, Inc.
PRA Health Sciences

Completed

Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers (BAL)

Healthy Subjects

United Kingdom
Jiangsu HengRui Medicine Co., Ltd.

Completed

Effect of Itraconazole on the Pharmacokinetics of SHR6390 in Healthy Subjects

Healthy Subjects

China
Mayo Clinic

Completed

Right Drug, Right Dose, Right Time - Using Genomic Data to Individualize Treatment

Healthy Subjects
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study to Investigate the Drug-drug Interactions (DDIs) Between SKLB1028 and Midazolam in Healthy Subjects

Healthy Subjects

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Active, not recruiting

A Study to Investigate the Drug-drug Interactions (DDIs) of SKLB1028 With Itraconazole, Gemfibrozil or Rifampicin in Healthy Subjects

Healthy Subjects

China
Venatorx Pharmaceuticals, Inc.

Completed

Safety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjects

Healthy Subjects

United States
Sintetica SA

Completed

Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

Healthy Subjects

Switzerland
Celltrion

Completed

Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects

Healthy Subjects

New Zealand
Amgen

Completed

A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast

Healthy Subjects

United States
Corium, Inc.

Completed

Crossover Pharmacokinetic (PK) Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteers

Healthy Subjects

United States
Liminal BioSciences Ltd.
Syneos Health

Terminated

Single Ascending Dose Study of PBI-4547 in Healthy Subjects

Healthy Subjects

Canada
Boston Pharmaceuticals

Completed

Study to Determine the Single and Repeat Dose Pharmacokinetics, Food Effect, Proton Pump Inhibitor (PPI) Drug Interaction, Safety and Tolerability of Oral Prototype Formulations of BOS172767 in Healthy Subjects

Healthy Subjects

United Kingdom

3

Subscribe